Xamoterol in severe heart failure

The Lancet

Volumn 336, Issue 8706, 1990, Pages 1-6

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; XAMOTEROL; XAMOTEROL HYDROGEN FUMARATE;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0025279763     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)91517-E     Document Type: Article

References (14)

1. 1-adrenoceptor partial agonist
2. 1 partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction
3. 1 partial agonist ('Corwin') with previous myocardial infarction
4. 1-adrenoceptor partial agonist, ICI 118,587
5. Die akute Wirkung des kardioselektiven beta-1-partiellen Agonisten, 'Corwin', auf die Ventrikelfunktion und den myocardialen Sauerstoffverbrauch bei Patienten mit dilativer Kardiomyopathie
6. 1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfuction
7. Double-blind placebo controlled comparison of digoxin and xamoterol in chronic heart failure
8. Addition of xamoterol to captopril in severe chronic heart failure
9. The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure with ACE-inhibitors
10. Effects of enalapril on mortality in severe congestive heart failure
11. Effects of captopril on survival in patients with heart failure
12. Long-term β-blockade in dilated cardiomyopathy. Effects of short and longterm metroprolol treatment followed by withdrawal and readministration of metoprolol
13. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure